The Hippo Transducer YAP/TAZ As a Biomarker of Therapeutic Response and Prognosis in Trastuzumab-Based Neoadjuvant Therapy Treated HER2-Positive Breast Cancer Patients.
Frontiers in Pharmacology（2020）
Key words
Trastuzumab-based neoadjuvant therapy,YAP,TAZ,HER2,HER3 heterodimer,breast cancer-free interval,SKBR-3 cell lines
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined